Form 4: BioLife Solutions CFO Troy Wichterman Sells Shares to Cover Tax Obligations

Troy Wichterman, CFO of BioLife Solutions, sold 159 shares of common stock on February 12, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

• On February 12, 2025, Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc., sold 159 shares of the company's common stock.
• The sale was executed at a price of $26.54 per share.
• Following the transaction, Wichterman directly owns 121,620 shares of BioLife Solutions Inc.
• The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on August 9, 2021.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by a company insider, which is neither particularly positive nor negative. The use of a pre-arranged trading plan mitigates concerns about insider trading.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives. The use of a 10b5-1 plan suggests the insider planned the transaction in advance to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of a small number of shares by the CFO is unlikely to have a significant impact on shareholders.

Key Dates

Keywords

BioLife Solutions, BLFS, Troy Wichterman, CFO, stock sale, Form 4, Rule 10b5-1, insider trading, tax obligations, restricted stock